Weiss Ratings reissued their sell (e+) rating on shares of 180 Life Sciences (NASDAQ:ATNF – Free Report) in a research report report published on Friday morning,Weiss Ratings reports.
180 Life Sciences Price Performance
180 Life Sciences stock opened at $1.18 on Friday. 180 Life Sciences has a 52 week low of $1.10 and a 52 week high of $17.75. The stock has a fifty day moving average of $1.45 and a 200-day moving average of $2.07.
Hedge Funds Weigh In On 180 Life Sciences
An institutional investor recently bought a new position in 180 Life Sciences stock. Rathbones Group PLC purchased a new position in shares of 180 Life Sciences Corp. (NASDAQ:ATNF – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 69,995 shares of the company’s stock, valued at approximately $127,000. Rathbones Group PLC owned approximately 2.20% of 180 Life Sciences as of its most recent filing with the SEC. 4.07% of the stock is currently owned by institutional investors and hedge funds.
180 Life Sciences Company Profile
180 Life Sciences Corp., a clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. The company product development platforms includes fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which has completed Phase IIb clinical trials that focuses on fibrosis and anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which are synthetic pharmaceutical grade molecules close or distant analogs of non-psychoactive cannabinoids, such as CBD for the treatment of inflammatory diseases and pain; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor.
See Also
- Five stocks we like better than 180 Life Sciences
- Trading Halts Explained
- Is Myers Industries Poised for a Breakout?
- What Are Growth Stocks and Investing in Them
- Is BigBear.ai’s 25% Plunge a False Alarm or Fire Sale?
- What is the Shanghai Stock Exchange Composite Index?
- Broadcom Confirmed Its AI Outlook: Stock to Hit New Highs Soon
Receive News & Ratings for 180 Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for 180 Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.